Department of Medical Pharmacology, Laboratory of Molecular Virology, University of Milan, Via Vanvitelli 32, Milan, Italy.
Arch Virol. 2010 Jun;155(6):915-24. doi: 10.1007/s00705-010-0663-7. Epub 2010 Apr 9.
Due to their natural host-range restriction to avian species, canarypox virus (CP) and fowlpox virus (FP) represent efficient and safe vaccine vectors, as they correctly express transgenes in human cells, elicit complete immune responses, and show protective efficacy in preclinical animal models. At present, no information is available on the differences in the abortive replication of these two avipox viruses in mammalian cells. In the present study, the replicative cycles of CP and FP, wild-type and recombinants, are compared in permissive and non-permissive cells, using transmission electron microscopy. We demonstrate that in non-permissive cells, the replicative cycle is more advanced in FP than in CP, that human cells, whether immune or not, are less permissive to avipox replication than monkey cells, and that the presence of virus-like particles only occurs after FP infection. Overall, these data suggest that the use of FP recombinants is more appropriate than the use of CP for eliciting an immune response.
由于其对禽类物种的天然宿主范围限制,金丝雀痘病毒(CP)和禽痘病毒(FP)是高效和安全的疫苗载体,因为它们在人类细胞中正确表达转基因,引发完全的免疫反应,并在临床前动物模型中显示出保护效力。目前,尚无关于这两种禽痘病毒在哺乳动物细胞中无效复制差异的信息。在本研究中,使用透射电子显微镜比较了 CP 和 FP、野生型和重组型在允许和不允许的细胞中的复制周期。我们证明,在不允许的细胞中,FP 的复制周期比 CP 更先进,免疫或非免疫的人类细胞比猴细胞对禽痘复制的允许性更低,只有在 FP 感染后才会出现病毒样颗粒。总的来说,这些数据表明,与 CP 相比,使用 FP 重组体引起免疫反应更为合适。